The Cost of Silence: Why Cutting HIV Vaccine Funding Threatens Global Health Equity
In early 2024, a quiet decision in the United States budget office set off alarm bells among global health experts. At a moment when scientific progress against HIV had finally turned a corner, the National Institutes of Health (NIH) abruptly cut $258 million in funding earmarked for some of the most promising vaccine development programmes in decades, including projects led by IAVI and Scripps Research. … Continue reading The Cost of Silence: Why Cutting HIV Vaccine Funding Threatens Global Health Equity
